The Cancer

Don't Miss

How Caregivers Can Assist Liked Ones With Lung Most cancers Really feel in Management

Chris Draft mentioned sufferers with lung most cancers and their caregivers can regain management after analysis by displaying up, staying knowledgeable and leaning into advocacy,...

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Elaine Riozzi Bodine and her daughter Alayna turned a life-altering analysis right into a mission to help different adolescents and younger adults with most cancers....

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Vital Information

Facts

Latest Articles

AU-007 Combo Dosing Begins in Melanoma Section 2 Trial With Opdivo

AU-007 routine has entered a section 2 melanoma trial, with early information displaying exercise and manageable security.The primary affected person has been dosed...

Trial of SVV-001, Opdivo and Yervoy in Neuroendocrine Tumors Launching

A section 1 medical trial is open for enrollment to sufferers with high-grade neuroendocrine tumors.A section 1 medical trial is now open for...

Ziftomenib Submits New Drug Utility to FDA for R/R NPM1-Mutant AML

The FDA beforehand granted breakthrough remedy designation to ziftomenib for relapsed/refractory NPM1-mutant acute myeloid leukemia.A New Drug Utility (NDA) has been submitted to...

Early Detection Crucial for Testicular Most cancers in Younger Males

April is Testicular Most cancers Consciousness Month, in keeping with the Testicular Most cancers Consciousness Basis, and since testicular most cancers is the...

Part 3 Trial Results in FDA Approval of Cabometyx in Neuroendocrine Tumors

The U.S. Meals and Drug Administration (FDA) has authorized Cabometyx (cabozantinib) for some sufferers 12 years of age and older with beforehand handled...

Hot Topics